{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T16:57:08Z","timestamp":1790873828207,"version":"4.1.0"},"reference-count":36,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2015,4,1]],"date-time":"2015-04-01T00:00:00Z","timestamp":1427846400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"Japan Intractable Diseases Research Foundation","award":["24790999"],"award-info":[{"award-number":["24790999"]}]},{"name":"Nagao Memorial Foundation"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Immunology"],"published-print":{"date-parts":[[2015,4]]},"DOI":"10.1016\/j.clim.2015.01.010","type":"journal-article","created":{"date-parts":[[2015,2,3]],"date-time":"2015-02-03T01:03:42Z","timestamp":1422925422000},"page":"114-120","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":41,"title":["Distinguishing the cerebrospinal fluid cytokine profile in neuropsychiatric systemic lupus erythematosus from other autoimmune neurological diseases"],"prefix":"10.1016","volume":"157","author":[{"given":"Kunihiro","family":"Ichinose","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuhiko","family":"Arima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takeshi","family":"Ushigusa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ayako","family":"Nishino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshikazu","family":"Nakashima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takahisa","family":"Suzuki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshiro","family":"Horai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hideki","family":"Nakajima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shin-ya","family":"Kawashiri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naoki","family":"Iwamoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mami","family":"Tamai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hideki","family":"Nakamura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomoki","family":"Origuchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masakatsu","family":"Motomura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Atsushi","family":"Kawakami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.clim.2015.01.010_bb0005","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1038\/nrrheum.2010.62","article-title":"Pathogenesis, diagnosis and management of neuropsychiatric SLE manifestations","volume":"6","author":"Bertsias","year":"2010","journal-title":"Nat. Rev. Rheumatol."},{"key":"10.1016\/j.clim.2015.01.010_bb0010","doi-asserted-by":"crossref","first-page":"457","DOI":"10.3109\/s10165-009-0198-5","article-title":"Pathogenesis of neuropsychiatric systemic lupus erythematosus and potential biomarkers","volume":"19","author":"Efthimiou","year":"2009","journal-title":"Mod. Rheumatol."},{"key":"10.1016\/j.clim.2015.01.010_bb0015","doi-asserted-by":"crossref","first-page":"1242","DOI":"10.1002\/art.22451","article-title":"Interleukin-6 and chemokines in the neuropsychiatric manifestations of systemic lupus erythematosus","volume":"56","author":"Fragoso-Loyo","year":"2007","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.clim.2015.01.010_bb0020","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1007\/s10067-009-1226-8","article-title":"Accuracy of cerebrospinal fluid IL-6 testing for diagnosis of lupus psychosis. A multicenter retrospective study","volume":"28","author":"Hirohata","year":"2009","journal-title":"Clin. Rheumatol."},{"key":"10.1016\/j.clim.2015.01.010_bb0025","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.pathophys.2010.04.008","article-title":"Neuromyelitis optica and opticospinal multiple sclerosis: mechanisms and pathogenesis","volume":"18","author":"Kira","year":"2011","journal-title":"Pathophysiology"},{"key":"10.1016\/j.clim.2015.01.010_bb0030","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1111\/bpa.12097","article-title":"Cytokines and chemokines in neuromyelitis optica: pathogenetic and therapeutic implications","volume":"24","author":"Uzawa","year":"2014","journal-title":"Brain Pathol."},{"key":"10.1016\/j.clim.2015.01.010_bb0035","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1002\/art.1780251101","article-title":"The 1982 revised criteria for the classification of systemic lupus erythematosus","volume":"25","author":"Tan","year":"1982","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.clim.2015.01.010_bb0040","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1002\/1529-0131(199904)42:4<599::AID-ANR2>3.0.CO;2-F","article-title":"The American College of Rheumatology nomenclature and case definitions for neuropsychiatric lupus syndromes","volume":"42","year":"1999","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.clim.2015.01.010_bb0045","doi-asserted-by":"crossref","first-page":"1485","DOI":"10.1212\/01.wnl.0000216139.44259.74","article-title":"Revised diagnostic criteria for neuromyelitis optica","volume":"66","author":"Wingerchuk","year":"2006","journal-title":"Neurology"},{"key":"10.1016\/j.clim.2015.01.010_bb0050","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1212\/01.wnl.0000333251.36681.a5","article-title":"A CSF biomarker panel for identification of patients with amyotrophic lateral sclerosis","volume":"72","author":"Mitchell","year":"2009","journal-title":"Neurology"},{"key":"10.1016\/j.clim.2015.01.010_bb0055","doi-asserted-by":"crossref","first-page":"e61835","DOI":"10.1371\/journal.pone.0061835","article-title":"Characteristic cerebrospinal fluid cytokine\/chemokine profiles in neuromyelitis optica, relapsing remitting or primary progressive multiple sclerosis","volume":"8","author":"Matsushita","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.clim.2015.01.010_bb0060","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1126\/science.286.5439.531","article-title":"Molecular classification of cancer: class discovery and class prediction by gene expression monitoring","volume":"286","author":"Golub","year":"1999","journal-title":"Science"},{"key":"10.1016\/j.clim.2015.01.010_bb0065","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1200\/JCO.2005.09.078","article-title":"Prediction of docetaxel response in human breast cancer by gene expression profiling","volume":"23","author":"Iwao-Koizumi","year":"2005","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.clim.2015.01.010_bb0070","doi-asserted-by":"crossref","first-page":"363","DOI":"10.3109\/03009742.2010.550900","article-title":"Cerebrospinal fluid levels of a proliferation-inducing ligand (APRIL) are increased in patients with neuropsychiatric systemic lupus erythematosus","volume":"40","author":"Hopia","year":"2011","journal-title":"Scand. J. Rheumatol."},{"key":"10.1016\/j.clim.2015.01.010_bb0075","doi-asserted-by":"crossref","first-page":"2218","DOI":"10.1093\/rheumatology\/ket294","article-title":"Inflammatory profile in cerebrospinal fluid of patients with headache as a manifestation of neuropsychiatric systemic lupus erythematosus","volume":"52","author":"Fragoso-Loyo","year":"2013","journal-title":"Rheumatology"},{"key":"10.1016\/j.clim.2015.01.010_bb0080","first-page":"485","article-title":"Kinins and cytokines in plasma and cerebrospinal fluid of patients with neuropsychiatric lupus","volume":"30","author":"Dellalibera-Joviliano","year":"2003","journal-title":"J. Rheumatol."},{"key":"10.1016\/j.clim.2015.01.010_bb0085","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1136\/ard.60.4.372","article-title":"Increased levels of proinflammatory cytokines and nitric oxide metabolites in neuropsychiatric lupus erythematosus","volume":"60","author":"Svenungsson","year":"2001","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.clim.2015.01.010_bb0090","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1097\/01.rhu.0000260637.95695.40","article-title":"Lupoid sclerosis: what is the role of antiphospholipid antibodies?","volume":"13","author":"Lima","year":"2007","journal-title":"J. Clin. Rheumatol."},{"key":"10.1016\/j.clim.2015.01.010_bb0095","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1016\/j.expneurol.2004.08.008","article-title":"Cytokines, nitric oxide, and cGMP modulate the permeability of an in vitro model of the human blood\u2013brain barrier","volume":"190","author":"Wong","year":"2004","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.clim.2015.01.010_bb0100","first-page":"119","article-title":"Prevention of cerebral edema and infarct in cerebral reperfusion injury by an antibody to interleukin-8","volume":"77","author":"Matsumoto","year":"1997","journal-title":"Lab. Invest."},{"key":"10.1016\/j.clim.2015.01.010_bb0105","doi-asserted-by":"crossref","first-page":"R551","DOI":"10.1186\/ar1228","article-title":"Intrathecal levels of matrix metalloproteinases in systemic lupus erythematosus with central nervous system engagement","volume":"6","author":"Trysberg","year":"2004","journal-title":"Arthritis Res. Ther."},{"key":"10.1016\/j.clim.2015.01.010_bb0110","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1161\/01.STR.0000259709.16654.8f","article-title":"Absence of the chemokine receptor CCR2 protects against cerebral ischemia\/reperfusion injury in mice","volume":"38","author":"Dimitrijevic","year":"2007","journal-title":"Stroke"},{"key":"10.1016\/j.clim.2015.01.010_bb0115","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1038\/sj.jcbfm.9600055","article-title":"Monocyte chemoattractant protein-1 regulation of blood\u2013brain barrier permeability","volume":"25","author":"Stamatovic","year":"2005","journal-title":"J. Cereb. Blood Flow Metab."},{"key":"10.1016\/j.clim.2015.01.010_bb0120","doi-asserted-by":"crossref","first-page":"943254","DOI":"10.1155\/2010\/943254","article-title":"IL-17 in systemic lupus erythematosus","volume":"2010","author":"Crispin","year":"2010","journal-title":"J. Biomed. Biotechnol."},{"key":"10.1016\/j.clim.2015.01.010_bb0125","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1111\/j.1365-2249.2009.03944.x","article-title":"Interleukin-17 and systemic lupus erythematosus: current concepts","volume":"157","author":"Nalbandian","year":"2009","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/j.clim.2015.01.010_bb0130","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1365-3083.2011.02536.x","article-title":"Th17 cell, the new player of neuroinflammatory process in multiple sclerosis","volume":"74","author":"Jadidi-Niaragh","year":"2011","journal-title":"Scand. J. Immunol."},{"key":"10.1016\/j.clim.2015.01.010_bb0135","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1073\/pnas.0903158107","article-title":"Homeostatic imbalance of regulatory and effector T cells due to IL-2 deprivation amplifies murine lupus","volume":"107","author":"Humrich","year":"2010","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.clim.2015.01.010_bb0140","doi-asserted-by":"crossref","first-page":"2168","DOI":"10.4049\/jimmunol.1400977","article-title":"IL-2 protects lupus-prone mice from multiple end-organ damage by limiting CD4-CD8- IL-17-producing T cells","volume":"193","author":"Mizui","year":"2014","journal-title":"J. Immunol."},{"key":"10.1016\/j.clim.2015.01.010_bb0145","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1093\/rheumatology\/36.2.190","article-title":"Cerebrospinal fluid soluble interleukin-2 receptor in cerebral lupus","volume":"36","author":"Gilad","year":"1997","journal-title":"Br. J. Rheumatol."},{"key":"10.1016\/j.clim.2015.01.010_bb0150","doi-asserted-by":"crossref","first-page":"740619","DOI":"10.1155\/2010\/740619","article-title":"The IL-2 defect in systemic lupus erythematosus disease has an expansive effect on host immunity","volume":"2010","author":"Lieberman","year":"2010","journal-title":"J. Biomed. Biotechnol."},{"key":"10.1016\/j.clim.2015.01.010_bb0155","doi-asserted-by":"crossref","first-page":"483","DOI":"10.4049\/jimmunol.154.2.483","article-title":"IL-15 has stimulatory activity for the induction of B cell proliferation and differentiation","volume":"154","author":"Armitage","year":"1995","journal-title":"J. Immunol."},{"key":"10.1016\/j.clim.2015.01.010_bb0160","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1093\/rheumatology\/40.8.876","article-title":"Serum interleukin-15 is elevated in systemic lupus erythematosus","volume":"40","author":"Aringer","year":"2001","journal-title":"Rheumatology"},{"key":"10.1016\/j.clim.2015.01.010_bb0165","doi-asserted-by":"crossref","first-page":"2740","DOI":"10.1002\/eji.200425267","article-title":"Transgene-mediated hyper-expression of IL-5 inhibits autoimmune disease but increases the risk of B cell chronic lymphocytic leukemia in a model of murine lupus","volume":"34","author":"Wen","year":"2004","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.clim.2015.01.010_bb0170","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1590\/S1807-59322011000100014","article-title":"IL-2, IL-5, TNF-alpha and IFN-gamma mRNA expression in epidermal keratinocytes of systemic lupus erythematosus skin lesions","volume":"66","author":"Carneiro","year":"2011","journal-title":"Clinics"},{"key":"10.1016\/j.clim.2015.01.010_bb0175","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1210\/edrv.18.1.0287","article-title":"The biology of vascular endothelial growth factor","volume":"18","author":"Ferrara","year":"1997","journal-title":"Endocr. Rev."},{"key":"10.1016\/j.clim.2015.01.010_bb0180","doi-asserted-by":"crossref","first-page":"627126","DOI":"10.1155\/2014\/627126","article-title":"Serum levels of three angiogenic factors in systemic lupus erythematosus and their clinical significance","volume":"2014","author":"Zhou","year":"2014","journal-title":"BioMed Res. Int."}],"container-title":["Clinical Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521661615000297?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521661615000297?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,8,2]],"date-time":"2023-08-02T20:41:54Z","timestamp":1691008914000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1521661615000297"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,4]]},"references-count":36,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2015,4]]}},"alternative-id":["S1521661615000297"],"URL":"https:\/\/doi.org\/10.1016\/j.clim.2015.01.010","relation":{},"ISSN":["1521-6616"],"issn-type":[{"value":"1521-6616","type":"print"}],"subject":[],"published":{"date-parts":[[2015,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Distinguishing the cerebrospinal fluid cytokine profile in neuropsychiatric systemic lupus erythematosus from other autoimmune neurological diseases","name":"articletitle","label":"Article Title"},{"value":"Clinical Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clim.2015.01.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}